Metabolic dysfunction-associated fatty liver disease (MAFLD) and non-alcoholic fatty liver disease (NAFLD): distinct fatty liver entities with different clinical outcomes?

Kaya, Eda; Zedginidze, Aleko; Bechmann, Lars; Canbay, Ali

Kaya, Eda; Zedginidze, Aleko; Bechmann, Lars; Canbay, Ali.

Afiliação

Kaya E; Section of Gastroenterology and Hepatology, University Hospital Knappschaftskrankenhaus Bochum, Ruhr University Bochum, Bochum, Germany.
Zedginidze A; Department of Internal Medicine, University Hospital Knappschaftskrankenhaus Bochum, Ruhr University Bochum, Bochum, Germany.
Bechmann L; Section of Gastroenterology and Hepatology, University Hospital Knappschaftskrankenhaus Bochum, Ruhr University Bochum, Bochum, Germany.
Canbay A; Department of Internal Medicine, University Hospital Knappschaftskrankenhaus Bochum, Ruhr University Bochum, Bochum, Germany.

Hepatobiliary Surg Nutr ; 11(2): 299-301, 2022 Apr.

Article em En | MEDLINE | ID: mdl-35464288

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article